Altria's (MO) Q4 Earnings Miss Estimates, Revenues Grow Y/Y
Altria Group Inc. MO came out with fourth-quarter 2020 results, wherein earnings declined year over year and fell short of the Zacks Consensus Estimate after delivering four straight beats. Nonetheless, revenues improved year over year, backed by strong pricing.
Quarter in Detail
Adjusted earnings came in at 99 cents per share, which dropped 2% year over year and fell short of the Zacks Consensus Estimate of $1.01. This is accountable to adjusted losses in the all other category, reduced adjusted earnings from the company’s equity investment in AB InBev BUD, elevated income taxes, escalated corporate expenses and a rise in financing costs, somewhat compensated by increased adjusted operating companies income (OCI) in the smokeable products segment.
Altria Group, Inc. Price, Consensus and EPS Surprise
Altria Group, Inc. price-consensus-eps-surprise-chart | Altria Group, Inc. Quote
Net revenues advanced 4.9% year over year to $6,304 million. Revenues, after deducting excise taxes, grew 5.3% to $5,055 million. The consensus mark was pegged at $4,933 million. Revenues were largely aided by increased revenues in the smokeable products segment, partly countered by reduced revenues in all other categories.
Segment Details
Smokeable Products: Net revenues in the category rose 7.9% year over year to $5,567 million, courtesy of higher pricing, partly negated by increased promotional investments. Revenues, net of excise taxes, grew 9.1% year over year to $4,355 million.
Reported domestic cigarette shipment volumes grew 3.1% year over year, thanks to trade inventory movements, somewhat countered by retail share losses. On adjusting for trade inventory movements, smokeable products’ domestic cigarette shipment volumes fell an estimated 1%, whereas total domestic cigarette industry volumes grew 0.5%. Meanwhile, Altria’s reported cigar shipment volumes improved 15%.
During the quarter, total cigarette retail share declined 0.3 percentage point to 49.3%. Adjusted OCI in the segment improved 9.2% to $2,388 million owing to better pricing and greater volumes, partly countered by higher promotional investments, increased resolution expenses and elevated costs. Adjusted OCI margin remained flat at 54.8%.
Oral Tobacco Products: Net revenues in the segment improved 4.5% from the year-ago quarter to $632 million, driven by greater pricing, somewhat countered by elevated promotional investments. Revenues, net of excise taxes, increased 4.5% to $600 million.
Domestic shipment volumes for the segment rose 0.5% mainly due to calendar differences and the industry’s growth rate, among other factors, partly countered by trade inventory movements and retail share losses (owing to an increase in oral nicotine pouch sales). On an adjusted basis, however, oral tobacco products shipment volumes climbed an estimated 0.5%. Total oral tobacco products’ retail share went down 2.4 percentage points to 49%.
Adjusted OCI rose 4.3% to $412 million owing to improved pricing, partly offset by greater promotional investments and higher costs. Adjusted OCI margin remained nearly flat at 68.7%.
Wine: This segment has been largely hurt by the pandemic in 2020, including on-premise as well as direct-to-consumer sales. Net revenues declined 12.6% year on year to $180 million due to reduced shipment volumes. The segment’s revenues, net of excise taxes, declined 12.5% to $175 million. Reported wine shipment volumes dropped 13.3% to about 2.1 million cases. The company’s wine business is likely to remain under pressure due to the restrictions on dining and gatherings.
Adjusted OCI in the category slumped 87% to $3 million, resulting from reduced shipment volumes and elevated costs. Adjusted OCI margin contracted 9.8 percentage points to 1.7%.
Financial Updates
A day prior to the earnings release, management approved a new share buyback program worth $2 billion, which is anticipated to conclude by Jun 30, 2022. Further, the company currently has an annualized dividend rate of $3.44 per share. Notably, the company maintains a long-term dividend payout ratio goal of about 80% of the adjusted EPS.
Altria ended the quarter with cash and cash equivalents of $4,945 million, long-term debt of $27,971 million and total stockholders’ equity of $2,925 million.
Other Developments & Guidance
Altria incurred pre-tax charges worth $50 million in 2020, related to COVID-19. These include costs related to personal protective equipment, and increased pay and health screenings, among others. However, the company noted that until now, its tobacco business has not witnessed any material disruption related to the government’s restrictions on consumer movements and business operations. Most of the retail stores where the company’s products are sold (like convenience stores) have been considered as essential businesses and remain open.
Notably, Altria has been benefiting from its non-combustible products. In December 2020, the IQOS 3 device was approved for sale in the United States by the U.S. Food and Drug Administration (FDA). During the fourth quarter, PM USA introduced IQOS devices for sale to certain convenience stores in Charlotte. Further, PM USA intends to expand IQOS and Marlboro HeatSticks to four new metro regions and surrounding areas in 2021. With regards to on!, Helix expanded its distribution by another 22,000 stores in the fourth quarter. on! is available in roughly 78,000 stores as of the end of the fourth quarter. This reflects growth of about 40% sequentially and more than five times the count from 2019-end. Moreover, on! has reached a retail share of 2.4 percentage points of the oral tobacco category in full-year 2020.
For 2021, the company envisions adjusted earnings per share in the range of $4.49-$4.62, indicating growth of 3-6% from $4.36 recorded in 2020. Altria continues to assess the macroeconomic impacts of the pandemic on adult tobacco consumers (ATCs), such as stay-at-home trends, disposable income, unemployment rates and buying patterns.
In fact, the company expects 2021 cigarette industry volumes to be most affected by factors like adult smokers, unemployment rates, cross-category movement, buying power, stay-at-home trends and the timing and breadth of the coronavirus vaccine, among others. That said, the company did not offer a cigarette industry guidance due to uncertainties surrounding the abovementioned aspects.
We note that shares of this Zacks Rank #3 (Hold) company have rallied 13.5% in the past three months compared with the industry’s growth of 14.9%.
Some Solid Staple Stocks
B&G Foods BGS, which currently carries a Zacks Rank #1 (Strong Buy), has a trailing four-quarter earnings surprise of 9.3%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
Nomad Foods NOMD has a Zacks Rank #2 (Buy) and a trailing four-quarter earnings surprise of 10.2%, on average.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by referendums and legislation, this industry is expected to blast from an already robust $17.7 billion in 2019 to a staggering $73.6 billion by 2027. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot stocks we're targeting >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Altria Group, Inc. (MO) : Free Stock Analysis Report
AnheuserBusch InBev SANV (BUD) : Free Stock Analysis Report
B&G Foods, Inc. (BGS) : Free Stock Analysis Report
Nomad Foods Limited (NOMD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
